Trial Profile
Safety and efficacy of amrubicin monotherapy in elderly patients with relapsed small cell lung cancer: A retrospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2018
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jan 2018 New trial record